0
Onconova Therapeutics, Inc. Banner Image

Onconova Therapeutics, Inc. has reached its limit for free report views

Work for Onconova Therapeutics, Inc.? Upgrade Your Profile and unlock all your annual reports.

Onconova Therapeutics, Inc.

  • Ticker ONTX
    Exchange NASDAQ More
  • Industry Biotechnology More
  • Sector Healthcare More
Onconova Therapeutics, Inc. Logo Image
  • 11-50 Employees
  • Based in Newtown, Pennsylvania
Onconova Therapeutics, Inc. is a Phase 3-stage biopharmaceutical company focused on discovering and developing novel small molecule drug candidates to treat cancer, with a primary focus on Myelodysplastic Syndromes (MDS). Rigosertib, Onconova's lead candidate, is a proprietary Phase 3 small molecule agent, which the Company believes blocks cellular signaling by targeting RAS effector pathways.
Onconova Therapeutics, Inc.

Most Recent Annual Report

Onconova Therapeutics, Inc. MOST RECENT 2019 Annual Report and Form 10K

Report Locked. Onconova Therapeutics, Inc. has reached its limit for free report views.

Older/Archived Annual Reports